Clinical Trial Update: PI Vs. NNRTI Based Therapy for HIV Advanced Disease [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update compares protease inhibitor–based therapy with NNRTI–based therapy for advanced HIV disease; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• Non-nucleoside reverse transcriptase inhibitor-based therapy (NNRTI)
• Protease inhibitor-based therapy (protease inhibitor)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Acquired Immunodeficiency Syndrome | Phase 4 | Status: UNKNOWN